Asabys Partners

📢 #PortfolioNews Congratulations to the Quibim team on achieving FDA 510(k) clearance for QP-Prostate®, an AI-powered solution that enhances early prostate cancer detection. This milestone represents a major step forward in medical imaging and personalized medicine, helping radiologists detect and diagnose clinically significant prostate cancer lesions (CADe/CADx) with greater precision. We are proud to support visionary teams like Quibim in transforming healthtech and improving patient care worldwide! 

Asabys at BioEurope Spring 2025 in Milan! This week, #BioEuropeSpring is bringing together key players in the biotech and investment ecosystem in Milan, fostering innovation and collaboration across the industry. We are excited to have Isabel Jiménez Bernal representing Asabys at the conference, connecting with entrepreneurs, investors, and industry leaders driving the next wave of healthcare innovation. If you’re attending and would like to meet, feel free to reach out! Looking forward to insightful discussions and new partnerships. #BioEuropeSpring #Biotech #HealthcareInnovation

📢 Portfolio news! Congratulations to the SpliceBio team on this significant clinical milestone! 👏 We are thrilled to see the first patient dosed in the Phase 1/2 ASTRA study of SB-007, the first dual AAV gene therapy in clinical development for Stargardt disease. This marks a crucial step forward in tackling a disease that has long been out of reach for gene therapy due to the large size of the ABCA4 gene. At Asabys, we are proud to support SpliceBio in their mission to develop innovative treatments for patients with high unmet medical needs. This achievement is a testament to the team’s expertise and dedication to advancing ophthalmology gene therapies. Exciting times ahead—looking forward to the next steps in this groundbreaking journey! 🚀  

Emilio Erazo-Fischer is attending Transfiere 2025, Spain’s leading deep-tech and innovation forum. A unique space to connect with cutting-edge technology, disruptive startups, and key industry leaders. If you're around, let’s connect and explore new investment and collaboration opportunities! #Transfiere2025 #Innovation #DeepTech #Networking

"Catalonia’s biotech ecosystem is thriving, driven by world-class science, strong investment, and bold entrepreneurship. At Asabys, we are committed to backing the next generation of game-changing health innovations." Maite Malet

📢 #PortfolioNews. Congratulations to the Agomab team on the positive interim results from the Phase 2a STENOVA trial for AGMB-129! A major milestone for the potential treatment of Fibrostenosing Crohn’s Disease (FSCD).

✨ Celebrating Innovation at Nit de Catalonia.Health (CataloniaBio & HealthTech)✨ Yesterday, Sylvain Sachot, Anna Bellmunt, and Isabel Jiménez Bernal attended the "Nit de Catalonia.Health", a fantastic event organized by Catalonia.Health (CataloniaBio & HealthTech) that brought together key players in the biotech, medtech, and digital health ecosystem. It was an inspiring evening full of innovation, collaboration, and recognition of the incredible work being done to drive the healthcare sector forward. Congratulations to the organizers for putting together such a meaningful gathering! Looking forward to the next edition! #CataloniaHealth #CataloniaBio #HealthTech #Innovation #HealthInnovation #MedTech #BioTech

How can venture capital and startups boost Europe’s competitiveness? Join our engaging panel discussion at #4YFN25 during MWC Barcelona! Maite Malet will be participating alongside experts from Adara Ventures, Wayra, JME Ventures, Ship2B Ventures, Abac Nest Ventures, and Seaya. Moderated by Yolanda Pérez Sáez (BStartup & Banco Sabadell), this panel promises a dynamic conversation filled with fresh insights and transformative ideas for the European innotation landscape. A special thank you to Banco Sabadell and BStartup for organizing this panel. Don't miss out on fresh insights and invaluable networking opportunities—see you there! 📅 Date: 3 March ⏰ Time: 5pm 📍 Location: Bstartup Stand, Hall 8.1 A40 #VC #Startups #Innovation #EuropeanCompetitiveness

La inversión en ciencia es clave para el futuro, y estamos encantados de haber participado en las Jornadas de #InvertirenCienciaSÍesrentable, en Santiago de Compostela. Isabel Jiménez Bernal ha participado en el panel "Retos para los inversores: inversión que genera beneficio" junto con Clave Capital, Bullnet Capital, Inveready , Ysios Capital, Swanlaab Venture Factory, Lanzadera, Zubi Capital y Biozell LLC, moderada por Xesgalicia. Esta Jornada ha reunido a inversores, emprendedores y expertos del sector para debatir sobre el impacto y las oportunidades que la inversión en ciencia y tecnología ofrece. Para Asabys, apoyar la innovación en salud y tecnología biomédica es un pilar fundamental, y estamos encantados de compartir nuestra visión. Gracias a los organizadores UNIRISCO, Noso Capital Bio & Tech Smart Capital y al patrocinador SpainCap por hacer posible esta jornada! #Ciencia #Innovación #Inversión #VentureCapital #Biotecnología

Celebrating impact-driven innovation! 🚀 Maite Malet represented Asabys Partners at the #ImpactPitch organized by Norrsken, joining a panel of investors committed to backing startups with world-changing potential. Thank you Norrsken for bringing together such an incredible community of founders and investors, creating a space where high-impact ventures can thrive. Congratulations to all the startups that pitched. Events like these are a testament to the power of innovation and collaboration in shaping a better future! Paula Cassà Nova (Ship2B Ventures), Carmen Pumariño (Zubi Capital), and Lara Viada (Creas) #ImpactInvesting #VentureCapital #Innovation